FDA Adverse Event Injury Summary report: N

SOLETRA

MDR report key: 2876418 · Received December 17, 2012

Report

Report Number
3004209178-2012-11959
Event Type
Injury
Date Received
December 17, 2012
Report Date
November 28, 2012
Manufacturer
MEDTRONIC MED REL MEDTRONIC PUERTO RICO
Product Code
MHY
PMA / PMN Number
P960009
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4).

Additional Manufacturer Narrative · 1

PRODUCT ID, 748240 LOT# SERIAL# (B)(4), IMPLANTED: 2006 (B)(6), PRODUCT TYPE EXTENSION PRODUCT ID, 748240 LOT# SERIAL# (B)(4), IMPLANTED: 2006 (B)(6), PRODUCT TYPE EXTENSION PRODUCT ID, 3387S-40 LOT# V012262, IMPLANTED: 2006 (B)(6), PRODUCT TYPE LEAD PRODUCT ID, 3387S-40 LOT# V014191, IMPLANTED: 2006 (B)(6), PRODUCT TYPE LEAD. (B)(4).

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PATIENT HAD A POCKET EROSION AND INFECTION OF THE LEFT IMPLANTABLE NEUROSTIMULATOR (INS). ADDITIONAL INFORMATION RECEIVED INDICATED THAT THE PATIENT HAD A REVISION/REPOSITIONING OF THE INS ON (B)(6) 2012. THE PATIENT FELT GOOD WITH GOOD TREMOR CONTROL. IT WAS NOTED THAT A NEW 95CM EXTENSION WAS TUNNELED DOWN THE PATIENT'S LEFT BACK TO A NEW INS LOCATED ON THE LOWER BACK. IT WAS UNCLEAR IF THE ORIGINAL POCKET WAS CULTURED.

Description of Event or Problem · 1

ADDITIONAL INFORMATION RECEIVED FROM THE HEALTH CARE PROVIDER REPORTED THAT THE CAUSE OF THE EVEN WAS SKIN EROSION OVER THE IMPLANTABLE NEUROSTIMULATOR (INS). A NEW INS WAS IMPLANTED. THE REVISION PROCEDURE HAPPENED ON (B)(6)-2012 WHERE REPLACEMENT AND REPOSITIONING OF THE INS OCCURRED. THE PATIENT SYMPTOMS ASSOCIATED WITH THE EVENT WAS REPORTED AS SKIN BREAKDOWN. THERE WAS NO PATIENT HOSPITALIZATION. THE PATIENT OUTCOME WAS REPORTED AS RECOVERED WITHOUT SEQUELA.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 SOLETRA STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN TREMOR MHY MEDTRONIC MED REL MEDTRONIC PUERTO RICO 7426

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention